Sherbrooke Park Advisers’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
RIM
Sherbrooke Park Advisers's IRMD Position: Q1 2025 in Review
Sherbrooke Park Advisers sold out of iRadimed (IRMD) in Q1 2025, closing a stake of 3,707 shares — an estimated $204K sold.
Sherbrooke Park Advisers first reported a position in IRMD in Q2 2024 and held it in 3 quarters. The position peaked at $378K in Q3 2024. 168 funds tracked by Wall St. Rank hold IRMD as of Q1 2025.
- Sherbrooke Park Advisers reported no remaining iRadimed position as of Q1 2025 after selling out during the quarter.
- Sherbrooke Park Advisers sold 3,707 iRadimed shares in Q1 2025, an estimated $204K.
- Sherbrooke Park Advisers first reported a position in iRadimed in Q2 2024 and held it in 3 quarters.
- Sherbrooke Park Advisers's iRadimed position peaked at $378K in Q3 2024.
- 168 funds tracked by Wall St. Rank held iRadimed as of Q1 2025.
Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.